This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Malta, Netherlands, Poland, Romania, Tunisia, Turkey, UK.
The drug DESFERAL contains one active pharmaceutical ingredient (API):
1
|
UNII
V9TKO7EO6K - DEFEROXAMINE MESYLATE
|
|
Deferoxamine is a chelating agent for trivalent iron and aluminium ions. The resulting chelates are stable and non-toxic. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| DESFERAL Sterile, lyophilised powder | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| V03AC01 | Deferoxamine | V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AC Iron chelating agents |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 526504501157411 |
| CA | Health Products and Food Branch | 01981242 |
| EE | Ravimiamet | 1116526, 1636725, 1784628, 1832442, 1866517, 1870152 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 189175 |
| FR | Base de données publique des médicaments | 68537836 |
| GB | Medicines & Healthcare Products Regulatory Agency | 142247, 37580 |
| HK | Department of Health Drug Office | 06780, 64622 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 528 |
| IT | Agenzia del Farmaco | 020417022 |
| JP | 医薬品医療機器総合機構 | 3929402D1036 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1090536, 1090640 |
| MT | Medicines Authority | MA1249/02201 |
| NL | Z-Index G-Standaard, PRK | 795 |
| PL | Rejestru Produktów Leczniczych | 100018155, 100330929, 100446974, 100456091 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W02408001 |
| TN | Direction de la Pharmacie et du Médicament | 10283161H |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699504790108 |
| US | FDA, National Drug Code | 0078-0467 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.